XOMA Royalty Corp. (XOMA)
41.67
-0.05
(-0.12%)
USD |
NASDAQ |
May 27, 15:52
XOMA Royalty Cash from Investing (Quarterly) : 6.552M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | -94.35M |
| Galera Therapeutics, Inc. | 0.00 |
| Organon & Co. | 386.00M |
| Rezolute, Inc. | 12.28M |
| Outlook Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.041M |
| Cash from Financing (Quarterly) | -7.56M |
| Free Cash Flow | -14.09M |
| Free Cash Flow Per Share (Quarterly) | 0.3468 |
| Free Cash Flow to Equity (Quarterly) | 12.86M |
| Free Cash Flow to Firm (Quarterly) | 9.759M |
| Free Cash Flow Yield | -1.89% |